CanBas Co., Ltd.

4575・Growth Market・Pharmaceuticals

Official website

CanBas Co., Ltd.

4575・Growth Market・Pharmaceuticals

Official website

CanBas Co., Ltd.4575

Reference Indicators

Market Cap

147¥100M

P/E (Forecast)

—

P/B

9.1x

Dividend Yield (Forecast)

0.00%

ROE

-58.0%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2022Jun 2022	2023Jun 2023	2024Jun 2024	2025Jun 2025	2026Jun 2026
SG&A Expenses	238	294	278	289	301
Operating Income	-846	-965	-1,262	-1,109	-1,358
Non-operating Income	0	4	59	1	50
Non-operating Expenses	8	321	5	48	—
Ordinary Income	-854	-1,283	-1,208	-1,156	-1,307
Extraordinary Income	—	40	—	—	—
Pre-tax Income	-854	-1,242	-1,208	-1,156	-1,307
Income Taxes	1	1	1	1	1
Net Income	-855	-1,244	-1,209	-1,157	-1,308
ROA	-108.2%	-59.6%	-49.7%	-38.0%	-73.7%
ROE	-535.4%	-65.5%	-52.5%	-39.8%	-58.0%